Mohamed, Mohamed F.AbdelKhalek, AhmedSeleem, Mohamed N.2020-09-212020-09-212016-07-112045-2322srep29707 (PII)http://hdl.handle.net/10919/100037Methicillin-resistant Staphylococcus aureus (MRSA) infections present a serious challenge because of the emergence of resistance to numerous conventional antibiotics. Due to their unique mode of action, antimicrobial peptides are novel alternatives to traditional antibiotics for tackling the issue of bacterial multidrug resistance. Herein, we investigated the antibacterial activity of two short novel peptides (WR12, a 12 residue peptide composed exclusively of arginine and tryptophan, and D-IK8, an eight residue β-sheet peptide) against multidrug resistant staphylococci. In vitro, both peptides exhibited good antibacterial activity against MRSA, vancomycin-resistant S. aureus, linezolid-resistant S. aureus, and methicillin-resistant S. epidermidis. WR12 and D-IK8 were able to eradicate persisters, MRSA in stationary growth phase, and showed significant clearance of intracellular MRSA in comparison to both vancomycin and linezolid. In vivo, topical WR12 and D-IK8 significantly reduced both the bacterial load and the levels of the pro-inflammatory cytokines including tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in MRSA-infected skin lesions. Moreover, both peptides disrupted established in vitro biofilms of S. aureus and S. epidermidis significantly more so than traditional antimicrobials tested. Taken together, these results support the potential of WR12 and D-IK8 to be used as a topical antimicrobial agent for the treatment of staphylococcal skin infections.14 page(s)Electronicapplication/pdfenCreative Commons Attribution 4.0 InternationalSOFT-TISSUE INFECTIONSPERSISTER CELLSANTIBIOTICSMECHANISMSDISEASESKINEPIDERMIDISVANCOMYCINPEXIGANANPENETRATIONKeratinocytesHumansStaphylococcus epidermidisStaphylococcal Skin InfectionsAntimicrobial Cationic PeptidesAnti-Bacterial AgentsMethicillin-Resistant Staphylococcus aureusArticle - Refereed2020-09-21https://doi.org/10.1038/srep2970761Seleem, Mohamed [0000-0003-0939-0458]27405275 (pubmed)2045-2322